Thrivewell Infusion has a dedicated team of clinical and administrative support for quality patient care and comfort. Our experienced physicians, nurse practitioners, pharmacists, concierge care coordinators, and leadership work together to provide a patient-centered approach to your individualized treatment within our state-of-the art infusion suites.

Led by the Thrivewell’s Medical Directors, Dr. Vikram Sengupta and Dr. Sascha Sengupta, our clinical team collaborates for a caring and compassionate approach toward care for a comfortable patient experience and quality clinical treatment.

Dr. Vikram Sengupta, MD

Chief Medical Officer

Born in Florida, Dr. Sengupta grew up in Bloomfield Hills, MI. He attended Cornell University, majoring in Neuroscience before moving on to the Yale School of Medicine where he earned his MD. He is fellowship trained in interventional pain management and board certified in internal medicine. His clinical areas of focus are regenerative medicine and neuromodulation. Dr. Sengupta is an experienced specialist in site-of-care optimization and the implementation of medical services. He has conducted groundbreaking, first-in-human clinical research using stem cell derived biologics to treat COVID-19 related ARDS and cytokine storm, as well as the use of implantable neurostimulation devices for the treatment of pain and is currently the primary investigator on several national multi-center clinical trials. He has served on faculty at Harvard and NYU.

Dr. Sengupta is committed to delivering personalized care in a safe, comfortable and convenient setting for all of his patients.

Selected Publications:

Peer Reviewed Journal Articles:

1) Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Stem Cells Dev. 2020 Jun 15;29(12):747-754.*

2) Sengupta V, Sengupta S, Lazo A Jr, Hicok KC, Moseley T. Response to Lim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19”. Stem Cells Dev. 2020 Jul;29(14):879-881.

*#1 most downloaded article for Stem Cells and Development in 2020 with > 90 citations to date.

Book Chapters:

1) Sengupta V, Qian S, Haider N. Pain Relieving Mechanisms of Neuromodulation.  Deer’s Treatment of Pain: An Illustrated Guide. (2019)

2) Qian S, Sengupta V, Haider N. Lumbar Sympathetic Block. Deer’s Treatment of Pain: An Illustrated Guide. (2019)

3) Haider N, Gates C, Sengupta V, Qian S. Cybersecurity of Medical Devices: Past, Present, and Future. Deer’s Treatment of Pain: An Illustrated Guide. (2019)

4) Qian S, Sengupta, V, Francis J.  Degenerative Spine Joint Disease. Spine Pain Care: A Comprehensive Clinical Guide (ed. Jianren Mao) (2019)

5) Qian S, Sengupta, V, Bremer N. Gasserian Ganglion Block. Deer’s Treatment of Pain: An Illustrated Guide. (2019)


1) Sengupta V, Qian, Urbiztondo N. Wireless peripheral nerve stimulation for compressive neuropathy of the lower extremity. [abstract and poster] International Neuromodulation Society. (2018)

2) Sengupta V, Haider N, Qian S. Spinal Cord Stimulator Lead Fractures Sustained by DRG Stimulator Trial. [abstract and poster]. North American Neuromodulation Society. (2017)

Dr. Sascha Sengupta, MD

Co-Founder & Associate Medical Director

Dr. Sengupta grew up in Atlanta, GA and attended Stanford University, majoring in biology with a minor in mathematics, and graduating with Phi Beta Kappa and honors before going on to Yale School of Medicine where she completed her MD. She then completed residency training in anesthesiology at Columbia-New York Presbyterian Hospital, followed by a fellowship in interventional pain management at Harvard Medical School’s Massachusetts General Hospital in Boston, MA. Her areas of clinical focus are regenerative medicine and neuromodulation.

She is devoted to helping those suffering from acute and chronic pain and illness and seeks to maximize her patients’ daily functioning and quality of life. She has published extensively and is an active clinical researcher in stem cell derived biologics and neuromodulation.

We are always looking for good and talented people


Copyright by Thrivewell 2017. All rights reserved.